EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-Cell Transcriptome Analysis of Small Cell Neuroendocrine Carcinoma of the Endometrium Reveals ISL1 as a Potential Biomarker for Diagnosis and Treatment

Cheng Zhong, Yu-E Guo, Qianlan Yang, Yunfeng Song, Tongshuai Wang, Bailian Cai, Hao Chen, He Du, Jing Wan, Yin Liu, Yiran Li, Xiaoping Wan

Frontiers in Bioscience-Landmark · 2024

DOI: 10.31083/j.fbl2903100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Cheng Zhong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Tongj…. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Carcinoma, Neuroendocrine. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of the Development Center of Shanghai Shenkang Hospital, Project of Clinical Science and Technology Innovation Project of Shanghai Shenkang Hospital Development Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

As a dedifferentiated tumor, small cell endometrial neuroendocrine tumors (NETs) are rare and frequently diagnosed at an advanced stage with a poor prognosis. Current treatment recommendations are often extrapolated from histologically similar tumors in other sites or based on retrospective studies. The exploration for diagnostic and therapeutic markers in small cell NETs is of great significance.

Methods

In this study, we conducted single-cell RNA sequencing on a specimen obtained from a patient diagnosed with small cell endometrial neuroendocrine carcinoma (SCNEC) based on pathology. We revealed the cell map and intratumoral heterogeneity of the cancer cells through data analysis. Further, we validated the function of ISL LIM Homeobox 1 (ISL1) in vitro in an established neuroendocrine cell line. Finally, we examined the association between ISL1 and tumor staging in small cell lung cancer (SCLC) patient samples.

Results

We observed the significant upregulation of ISL1 expression in tumor cells that showed high expression of the neuroepithelial markers. Additionally, in vitro cell function experiments demonstrated that the high ISL1 expression group exhibited markedly higher cell proliferation and migration abilities compared to the low expression group. Finally, we showed that the expression level of ISL1 was correlated with SCLC stages.

Conclusions

ISL1 protein in NETs shows promise as a potential biomarker for diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsCarcinoma, NeuroendocrineFemaleHumansTranscription FactorsRetrospective StudiesSingle-Cell Gene Expression AnalysisLIM-Homeodomain ProteinsBiomarkers, TumorEndometrium

Stichwörter der Autor:innen

ISL1cell proliferation and migrationsingle-cell RNA sequencinguterine neuroendocrine tumors

Substanzen

Transcription FactorsLIM-Homeodomain ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, 200120 Shanghai, China.
  • Department of Pharmacy, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 200433 Shanghai, China.
  • Department of Oncology, Shanghai Pulmonary Hospital Affiliated to Tongji University School of Medicine, 200433 Shanghai, China.
  • Department of Gynecologic Oncology, International Peace Maternity & Child Health Hospital of China Welfare Institute, Shanghai Jiaotong University, 200030 Shanghai, China.
  • Department of Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 200433 Shanghai, China.

Förderung

  • National Natural Science Foundation of China
  • Project of the Development Center of Shanghai Shenkang Hospital
  • Project of Clinical Science and Technology Innovation Project of Shanghai Shenkang Hospital Development Center
  • Special Project of Health Industry of Pudong New Area Health Commission
  • Dream Mentor-Outstanding Young Talents Program of Shanghai Pulmonary Hospital
  • 2021 Shanghai "Medical Garden Rising Stars" Young Medical Talents of Shanghai Municipal Health Commission Award
  • Shanghai Pujiang Program
  • 2021 Shanghai “Medical Garden Rising Stars” Young Medical Talents of Shanghai Municipal Health Commission Award

Zitieren

APA

Zhong, C., Guo, Y. E., Yang, Q., Song, Y., Wang, T., Cai, B., Chen, H., Du, H., Wan, J., Liu, Y., Li, Y., & Wan, X. (2024). Single-Cell Transcriptome Analysis of Small Cell Neuroendocrine Carcinoma of the Endometrium Reveals ISL1 as a Potential Biomarker for Diagnosis and Treatment. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2903100

Vancouver

Zhong C, Guo YE, Yang Q, Song Y, Wang T, Cai B, et al. Single-Cell Transcriptome Analysis of Small Cell Neuroendocrine Carcinoma of the Endometrium Reveals ISL1 as a Potential Biomarker for Diagnosis and Treatment. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2903100

BibTeX
@article{Zhong2024,
  author = {Zhong, Cheng and Guo, Yu-E and Yang, Qianlan and Song, Yunfeng and Wang, Tongshuai and Cai, Bailian and Chen, Hao and Du, He and Wan, Jing and Liu, Yin and Li, Yiran and Wan, Xiaoping},
  title = {Single-Cell Transcriptome Analysis of Small Cell Neuroendocrine Carcinoma of the Endometrium Reveals ISL1 as a Potential Biomarker for Diagnosis and Treatment},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  doi = {10.31083/j.fbl2903100}
}
Kostenlos starten →